Emerald Advisers Inc. PA has $ 14.54 million at Tabula Rasa HealthCare Inc. (NASDAQ: TRHC)


Emerald Advisers Inc. In the third quarter, PA decreased its share in Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) by 51.0%, according to the company, in its latest filing with the Securities and Exchange Commission. The institutional investor owned 179,035 company shares after selling 186,463 shares in the quarter. Emerald Advisers Inc. PA had approximately 0.88% of Tabula Rasa HealthCare worth 14,536 thousand dollars from its latest SEC application.

Other institutional investors also bought and sold company shares. BlackRock Inc. in the second quarter, increased its stake in Tabula Rasa HealthCare by 29.7%. BlackRock Inc. now owns 2,119,507 shares of the company in the amount of $ 135,288,000, after acquiring an additional 484,979 shares in the fourth quarter. Jennison Associates LLC raised its position in Tabula Rasa HealthCare shares by 29.5% in the 2nd quarter. Jennison Associates LLC now owns 757,846 shares of the company, worth $ 48,373,000, after purchasing an additional 172,693 shares during that period. NN Investment Partners Holding N.V. in the third quarter increased its stake in Tabula Rasa HealthCare shares by 45.2%. Company NN Investment Partners N.V. owns 669,800 shares of the company in the amount of US $ 54,380,000, after purchasing an additional 208,604 shares during that period. Braun Stacey Associates Inc. in the second quarter, raised its position in Tabula Rasa HealthCare shares by 199.0%. Braun Stacey Associates Inc. owns 301,089 shares of the company in the amount of 19,219,000 dollars after purchasing an additional 200,394 shares during this period. Finally, the North Trust Corp. raised its position in Tabula Rasa HealthCare shares by 52.3% in the second quarter. The North Trust Corp. now owns 227,503 shares of the company worth $ 14,522,000 after purchasing an additional 78,112 shares during this period. Hedge funds and other institutional investors hold 75.36% of the company's stock.

TRHC opened on Friday at $ 66.57. The company has a market limit of $ 1.33 billion, a P / E ratio of -1,664.25, a PEG ratio of 6.12 and a beta of 2.58. The company currently has a ratio of 0.49, a quick ratio of 0.46 and a ratio between debt and equity of 0.28. Tabula Rasa HealthCare Inc. has a one-year low value of $ 27.25 and a one-year value of $ 91.16.

Tabula Rasa HealthCare (NASDAQ: TRHC) announced its quarterly earnings results on Tuesday, November 6th. In the fourth quarter, the company reported a 0.26% EPS value, assessing Thomson Reuters's consensus estimate of 0.19 euros for 0.07 euros. The company had 54.42 million revenue for the quarter, compared with analysts' estimates of 52.87 million dollars. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity 7.63%. The company's revenues increased by 66.3% over the year. In the same quarter of last year, the company earned $ 0.08 earnings per share. Research analysts predict that Tabula Rasa HealthCare Inc. will publish 0.42 net earnings per share for the current year.

Many share research researchers recently commented on TRHC shares. BidaskClub cut Tabula Rasa HealthCare shares from the "buy" rating to a "hold" rating in a Quarterly survey report. Zacks Investment Research cuts Tabula Rasa HealthCare's shares from the "hold" rating to "sell" a rating in a research report on Saturday, November 10th. Chardan Capital raised its price target for Tabula Rasa HealthCare shares from $ 77.00 to $ 91.00, while the report on Wednesday, November 7, gave a "buy" rating. Cantor Fitzgerald reaffirmed the "Buy" estimate and issued a $ 99.00 price tag for shares in Tabula Rasa HealthCare in a report Tuesday, November 6th. Finally, Citigroup raised its price target to Tabula Rasa HealthCare shares at $ 100.00 and gave a "buy" rating on Thursday, October 11th. One equity analyst estimated the stock with a credit rating of sales, two had an asset assessment, and ten companies assigned a credit rating to the company. Tabula Rasa HealthCare currently has an average "Buy" rating and an average price of $ 81.60.

In related news, President Orsula V. Knowlton bought 7,500 shares of the company on Monday, November 12th. Shares were acquired at an average price of USD 65.00 per share, with a total value of USD 487,500.00. The transaction was disclosed in a document that was filed with the Securities and Exchange Commission, which you can access through this link. The president of Orsula, V. Knowlton, also sold 8,000 shares of the company in a transaction on September 17th. The stock was sold at an average price of $ 79.80 for the entire transaction of $ 638,400. Disclosure for this sale can be found here. Over the last 90 days, 40,000 shares of the company were sold in the amount of $ 3,145,120. The owners of the 14% share of the company have the owner.

FAIR RIGHTEOUS NOTICE: This report originally reported Fairfield Current and is a property of Fairfield Current. If you are viewing this report in another publication, it was unlawfully stolen and republished in violation of the international copyright and trademark law. You can view the correct version of this report at https://www.fairfieldcurrent.com/2018/11/17/emerald-advisers-inc-pa-has-14-54-million-position-in-tabula-rasa- healthcare- inc-trhc.html.

About Health Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc. acts as a healthcare company in the United States. It offers risk management for medicines, management of medicinal products costs and services for adapting the risks to treatment. The company offers its technology products and services to regulated pharmacists and healthcare organizations to manage drug risks and adapt the risks.

Featured Story: moving average (MA)

Institutional ownership of the fourth quarter for Tabula Rasa HealthCare (NASDAQ: TRHC)

Receive news and ratings for daily health Tabula Rasa HealthCare – Enter your email address below to receive a condensed daily summary of the latest news and analyst estimates for Tabula Rasa HealthCare and related companies with Free Daily News MarketBeat.com.


Source link